Home

OrbiMed Advisors Israel II Ltd

CIK 1682093 · last filed 2024-10-17

OrbiMed Advisors Israel II Ltd is a corporate insider who has filed 13 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for ACET, was dated Apr 8, 2026. Across all open-market trades the lifetime net is +$208.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $29.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$29.66M

Companies

3

Total Filings

13

Lifetime Open-Market Net

$208.14M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
UPB Director 4,554,873 $6.40 $29.15M $56.10M 1 2024-10-17
ACET Director 61,891 $8.20 $507.5K $60.00M 2 2024-01-26
LogicBio Therapeutics, Inc. (LOGC) Delisted Director 3,524,997 $7.06 $24.89M $92.04M 2 2020-10-05

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-08 ACET Notice (144) −40,416 -$264.7K EDGAR
2024-10-17 UPB Mixed +17,739,156 $56.10M EDGAR
2024-01-26 ACET Buy (P) +25,000,000 $60.00M EDGAR
2023-10-02 DMRA Notice (144) −244,527 -$176.1K EDGAR
2023-08-30 DMRA Notice (144) −510,610 -$296.2K EDGAR
2023-08-21 DMRA Notice (144) −631,048 -$389.4K EDGAR
2023-08-15 DMRA Notice (144) −489,970 -$367.5K EDGAR
2023-07-31 DMRA Notice (144) −180,300 -$544.5K EDGAR
2023-07-25 DMRA Notice (144) −4,700 -$11.0K EDGAR
2023-07-13 DMRA Notice (144) −52,800 -$134.6K EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.